Deciphera Pharmaceuticals, Inc. Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number
Deciphera Pharmaceuticals, Inc. had Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number of 9.26 million shares as of 2023-12-31, per its 10-K filed 2024-02-07.
Discontinued › Notes › Compensation Related Costs › Share-Based Payment Arrangement, Disclosure
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber · last filed 2024-02-07
- 2023-12-31: Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number 9.26M shares.
- 2022-12-31: Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number 8.28M shares.
- 2021-12-31: Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number 7.44M shares.
- 2020-12-31: Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number 5.71M shares.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number |
|---|---|
| 2023-12-31 | 9.26M shares 10-K · filed 2024-02-07 |
| 2022-12-31 | 8.28M shares 10-K · filed 2024-02-07 |
| 2021-12-31 | 7.44M shares 10-K · filed 2023-02-07 |
| 2020-12-31 | 5.71M shares 10-K · filed 2022-02-08 |
| 2019-12-31 | 6.75M shares 10-K · filed 2021-02-09 |
| 2018-12-31 | 5.79M shares 10-K · filed 2020-03-09 |
| 2017-12-31 | 4.60M shares 10-K · filed 2019-03-14 |
| 2016-12-31 | 3.21M shares 10-K · filed 2018-03-28 |